ME00562A - Novi oblik soli pantoprazola - Google Patents

Novi oblik soli pantoprazola

Info

Publication number: ME00562A
Authority: ME; Montenegro
Prior art keywords: pantoprazole; salt form; novel salt; novel; relates
Prior art date: 1998-08-18

Application number

MEP-847/08A

Other languages

English (en)

Croatian (hr)

Inventor

Bernhard Kohl

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-08-18

Filing date

1999-08-12

Publication date

2011-12-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7881823&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME00562(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-08-12 Application filed filed Critical

2011-12-20 Publication of ME00562B publication Critical patent/ME00562B/me

2011-12-20 Publication of ME00562A publication Critical patent/ME00562A/bs

Links

IQPSEEYGBUAQFF-UHFFFAOYSA-N Pantoprazole Chemical compound COC1=CC=NC(CS(=O)C=2NC3=CC=C(OC(F)F)C=C3N=2)=C1OC IQPSEEYGBUAQFF-UHFFFAOYSA-N 0.000 title 1
229960005019 pantoprazole Drugs 0.000 title 1
150000003839 salts Chemical group 0.000 title 1
RDRUTBCDIVCMMX-UHFFFAOYSA-N magnesium;5-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]benzimidazol-1-ide Chemical class [Mg+2].COC1=CC=NC(CS(=O)C=2[N-]C3=CC=C(OC(F)F)C=C3N=2)=C1OC.COC1=CC=NC(CS(=O)C=2[N-]C3=CC=C(OC(F)F)C=C3N=2)=C1OC RDRUTBCDIVCMMX-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Medicinal Preparation (AREA)
Detergent Compositions (AREA)
Manufacture And Refinement Of Metals (AREA)
Drying Of Gases (AREA)
Solid-Sorbent Or Filter-Aiding Compositions (AREA)

MEP-847/08A 1998-08-18 1999-08-12 Novi oblik soli pantoprazola ME00562A (bs)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE19843413A DE19843413C1 (de)	1998-08-18	1998-08-18	Neue Salzform von Pantoprazol
PCT/EP1999/005928 WO2000010995A1 (en)	1998-08-18	1999-08-12	Novel salt form of pantoprazole
YUP-113/01A RS50071B (sr)	1998-08-18	1999-08-12	Novi oblik soli pantoprazola

Publications (2)

Publication Number	Publication Date
ME00562B ME00562B (me)	2011-12-20
ME00562A true ME00562A (bs)	2011-12-20

Family

ID=7881823

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MEP-847/08A ME00562A (bs)	1998-08-18	1999-08-12	Novi oblik soli pantoprazola

Country Status (32)

Country	Link
US (2)	US6410569B1 (bs)
EP (1)	EP1105386B1 (bs)
JP (1)	JP2002523411A (bs)
KR (1)	KR100657835B1 (bs)
CN (1)	CN1146558C (bs)
AT (1)	ATE219074T1 (bs)
AU (1)	AU761715B2 (bs)
BG (1)	BG65255B1 (bs)
BR (1)	BR9914288A (bs)
CA (1)	CA2341031C (bs)
CZ (1)	CZ293734B6 (bs)
DE (3)	DE19843413C1 (bs)
DK (1)	DK1105386T3 (bs)
EA (1)	EA004431B1 (bs)
EE (1)	EE04278B1 (bs)
ES (1)	ES2178896T3 (bs)
HR (1)	HRP20010117B1 (bs)
HU (1)	HU226618B1 (bs)
IL (3)	IL141328A0 (bs)
ME (1)	ME00562A (bs)
MX (1)	MXPA01001758A (bs)
NO (1)	NO319782B1 (bs)
NZ (1)	NZ509761A (bs)
PL (1)	PL198801B1 (bs)
PT (1)	PT1105386E (bs)
RS (1)	RS50071B (bs)
SI (1)	SI1105386T1 (bs)
SK (1)	SK285105B6 (bs)
TR (1)	TR200100287T2 (bs)
UA (1)	UA58605C2 (bs)
WO (1)	WO2000010995A1 (bs)
ZA (1)	ZA200100934B (bs)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19843413C1 (de) *	1998-08-18	2000-03-30	Byk Gulden Lomberg Chem Fab	Neue Salzform von Pantoprazol
MY137726A (en) *	2000-11-22	2009-03-31	Nycomed Gmbh	Freeze-dried pantoprazole preparation and pantoprazole injection
DE10234617B4 (de) *	2002-07-29	2013-04-04	Nycomed Gmbh	Neues Salz von (S)-Pantoprazol
TW200410955A (en) *	2002-07-29	2004-07-01	Altana Pharma Ag	Novel salt of (S)-PANTOPRAZOLE
EP1572680A2 (en) *	2002-12-19	2005-09-14	Eva Pharmaceutical Industries Ltd.	Solid states of pantoprazole sodium, known pantoprazole sodium hydrates, processes for their preparation.
AU2004237362A1 (en) *	2003-05-06	2004-11-18	Altana Pharma Ag	Proton pump inhibitors for the treatment of lower abdominal disorders
PE20050150A1 (es) *	2003-05-08	2005-03-22	Altana Pharma Ag	Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
CL2004000983A1 (es) *	2003-05-08	2005-03-04	Altana Pharma Ag	Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
WO2004100949A2 (en) *	2003-05-19	2004-11-25	Pliva-Istrazivanje I Razvoj D.O.O.	Solid-state forms of 5-(difluoromethoxy)-2-((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-1h-benzimidazole (pantoprazole) sodium aqua complexes
MXPA05013316A (es) *	2003-06-10	2006-03-17	Teva Pharma	Proceso para preparar bencimidazoles 2[-(piridinil)metil]sulfinil-sustituidos y derivados clorados novedosos de pantoprazol.
WO2005012289A1 (en) *	2003-07-17	2005-02-10	Altana Pharma Ag	Novel salt of (r) - pantoprazole
CN100457104C (zh) *	2003-07-23	2009-02-04	尼科梅德有限责任公司	质子泵抑制剂的碱性盐
MXPA06000652A (es) *	2003-07-23	2006-03-30	Altana Pharma Ag	Sales alcalinas de inhibidores de bomba de protones.
WO2005074930A1 (en) *	2004-01-28	2005-08-18	Altana Pharma Ag	Pharmaceutical combinations of (s) -pantoprazole with nsaid or corticosteroids
WO2005074931A1 (en) *	2004-01-28	2005-08-18	Altana Pharma Ag	Pharmaceutical combinations comprising (s) -pantoprazole
EP1711179A2 (en) *	2004-01-28	2006-10-18	Altana Pharma AG	Calcium, potassium, zinc, lithium and aluminium salts of pantoprazole and (s)-pantoprazole
WO2005074932A1 (en) *	2004-01-28	2005-08-18	Altana Pharma Ag	The use of (s) - pantoprazole magnesium for the treatment of airway disorders
WO2005074898A2 (en) *	2004-01-28	2005-08-18	Altana Pharma Ag	Composition comprising (s) pantoprazole and an antibiotic for treating helicobacter pylori
WO2005077936A1 (en) *	2004-02-11	2005-08-25	Ulkar Kimya Sanayii Ve Ticaret A.S.	Pyridine benzimidazole sulfoxides with high purity
WO2005082888A1 (en) *	2004-03-01	2005-09-09	Milen Merkez Ilac Endustrisi A.S.	Process for the preparation of magnesium salt of omeprazole
AU2005239838B2 (en) *	2004-05-07	2011-08-11	Takeda Gmbh	Pharmaceutical dosage form comprising pellets as well as its manufacturing process
WO2007041790A1 (en) *	2005-10-14	2007-04-19	Jon Pty Limited	Salts of proton pump inhibitors and process for preparing same
US20080139623A1 (en)	2006-06-12	2008-06-12	Lilach Hedvati	Amorphous and crystalline forms of pantoprazole magnesium salt
EP1960388A1 (en) *	2006-11-06	2008-08-27	Teva Pharmaceutical Industries Ltd.	Processes for preparing substantially pure pantoprazole magnesium
EP3187494A1 (en) *	2015-12-30	2017-07-05	KRKA, tovarna zdravil, d.d., Novo mesto	Process for the preparation of pantoprazole sodium sesquihydrate
EP3397630B1 (en) *	2015-12-30	2021-05-26	KRKA, tovarna zdravil, d.d., Novo mesto	Process for the preparation of pantoprazole sodium sesquihydrate

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE7804231L (sv) *	1978-04-14	1979-10-15	Haessle Ab	Magsyrasekretionsmedel
IL75400A (en) *	1984-06-16	1988-10-31	Byk Gulden Lomberg Chem Fab	Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) *	1984-08-16	1986-03-13	Takeda Chem Ind Ltd	ピリジン誘導体およびその製造法
FI90544C (fi) *	1986-11-13	1994-02-25	Eisai Co Ltd	Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
DE4018642C2 (de) *	1990-06-11	1993-11-25	Byk Gulden Lomberg Chem Fab	Neue Salzform des 5-Difluormethoxy-2-[(3,4-dimethoxy-2-pyridyl) methylsulfinyl]-1H-benzimitazol-Natriumsalzes
YU48263B (sh) *	1991-06-17	1997-09-30	Byk Gulden Lomberg Chemische Fabrik Gmbh.	Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
SE9302396D0 (sv) *	1993-07-09	1993-07-09	Ab Astra	A novel compound form
SE9600070D0 (sv) *	1996-01-08	1996-01-08	Astra Ab	New oral pharmaceutical dosage forms
SE508669C2 (sv) *	1996-04-26	1998-10-26	Astra Ab	Nytt förfarande
DE19843413C1 (de) *	1998-08-18	2000-03-30	Byk Gulden Lomberg Chem Fab	Neue Salzform von Pantoprazol

1998
- 1998-08-18 DE DE19843413A patent/DE19843413C1/de not_active Expired - Fee Related
1999
- 1999-08-12 AU AU55156/99A patent/AU761715B2/en not_active Ceased
- 1999-08-12 DE DE69901840T patent/DE69901840T2/de not_active Expired - Lifetime
- 1999-08-12 KR KR1020017001911A patent/KR100657835B1/ko not_active Expired - Lifetime
- 1999-08-12 WO PCT/EP1999/005928 patent/WO2000010995A1/en not_active Ceased
- 1999-08-12 PL PL345993A patent/PL198801B1/pl unknown
- 1999-08-12 HU HU0103257A patent/HU226618B1/hu not_active IP Right Cessation
- 1999-08-12 JP JP2000566268A patent/JP2002523411A/ja active Pending
- 1999-08-12 US US09/762,303 patent/US6410569B1/en not_active Expired - Lifetime
- 1999-08-12 BR BR9914288-0A patent/BR9914288A/pt not_active Application Discontinuation
- 1999-08-12 CZ CZ2001621A patent/CZ293734B6/cs not_active IP Right Cessation
- 1999-08-12 ME MEP-847/08A patent/ME00562A/bs unknown
- 1999-08-12 AT AT99941605T patent/ATE219074T1/de active
- 1999-08-12 EA EA200100208A patent/EA004431B1/ru not_active IP Right Cessation
- 1999-08-12 EP EP99941605A patent/EP1105386B1/en not_active Expired - Lifetime
- 1999-08-12 MX MXPA01001758A patent/MXPA01001758A/es active IP Right Grant
- 1999-08-12 TR TR2001/00287T patent/TR200100287T2/xx unknown
- 1999-08-12 EE EEP200100054A patent/EE04278B1/xx unknown
- 1999-08-12 IL IL14132899A patent/IL141328A0/xx unknown
- 1999-08-12 ES ES99941605T patent/ES2178896T3/es not_active Expired - Lifetime
- 1999-08-12 IL IL14115799A patent/IL141157A0/xx active IP Right Grant
- 1999-08-12 DE DE1999601840 patent/DE122005000049I2/de active Active
- 1999-08-12 HR HR20010117A patent/HRP20010117B1/xx not_active IP Right Cessation
- 1999-08-12 CA CA002341031A patent/CA2341031C/en not_active Expired - Lifetime
- 1999-08-12 CN CNB998098000A patent/CN1146558C/zh not_active Expired - Fee Related
- 1999-08-12 PT PT99941605T patent/PT1105386E/pt unknown
- 1999-08-12 SI SI9930096T patent/SI1105386T1/xx unknown
- 1999-08-12 NZ NZ509761A patent/NZ509761A/en not_active IP Right Cessation
- 1999-08-12 SK SK236-2001A patent/SK285105B6/sk not_active IP Right Cessation
- 1999-08-12 DK DK99941605T patent/DK1105386T3/da active
- 1999-08-12 RS YUP-113/01A patent/RS50071B/sr unknown
- 1999-12-08 UA UA2001021133A patent/UA58605C2/uk unknown
2001
- 2001-01-23 BG BG105173A patent/BG65255B1/bg unknown
- 2001-01-29 IL IL141157A patent/IL141157A/en not_active IP Right Cessation
- 2001-02-02 ZA ZA200100934A patent/ZA200100934B/en unknown
- 2001-02-12 NO NO20010718A patent/NO319782B1/no not_active IP Right Cessation
2002
- 2002-05-01 US US10/135,528 patent/US6686379B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
NO20010718L (no)	2001-02-12
CA2341031C (en)	2006-04-04
HU226618B1 (en)	2009-04-28
ATE219074T1 (de)	2002-06-15
PT1105386E (pt)	2002-11-29
IL141157A (en)	2007-06-17
DE122005000049I2 (de)	2007-03-29
CA2341031A1 (en)	2000-03-02
EE200100054A (et)	2002-06-17
DE122005000049I1 (de)	2006-12-28
US20020188008A1 (en)	2002-12-12
IL141328A0 (en)	2002-03-10
TR200100287T2 (tr)	2001-07-23
DE69901840D1 (de)	2002-07-18
CN1146558C (zh)	2004-04-21
RS50071B (sr)	2009-01-22
CN1318065A (zh)	2001-10-17
PL198801B1 (pl)	2008-07-31
CZ293734B6 (cs)	2004-07-14
EE04278B1 (et)	2004-04-15
US6410569B1 (en)	2002-06-25
JP2002523411A (ja)	2002-07-30
ZA200100934B (en)	2002-03-04
HK1037616A1 (en)	2002-02-15
IL141157A0 (en)	2002-02-10
DK1105386T3 (da)	2002-09-30
BG65255B1 (bg)	2007-10-31
KR100657835B1 (ko)	2006-12-15
CZ2001621A3 (cs)	2001-08-15
HUP0103257A2 (hu)	2002-02-28
NO20010718D0 (no)	2001-02-12
KR20010072487A (ko)	2001-07-31
DE19843413C1 (de)	2000-03-30
EP1105386A1 (en)	2001-06-13
WO2000010995A1 (en)	2000-03-02
EP1105386B1 (en)	2002-06-12
YU11301A (sh)	2003-12-31
MXPA01001758A (es)	2002-04-17
BG105173A (en)	2001-11-30
EA200100208A1 (ru)	2001-08-27
ME00562B (me)	2011-12-20
UA58605C2 (uk)	2003-08-15
HRP20010117B1 (en)	2010-07-31
HRP20010117A2 (en)	2002-02-28
PL345993A1 (en)	2002-01-14
HUP0103257A3 (en)	2003-01-28
NZ509761A (en)	2003-08-29
SI1105386T1 (en)	2002-12-31
EA004431B1 (ru)	2004-04-29
NO319782B1 (no)	2005-09-12
ES2178896T3 (es)	2003-01-01
AU761715B2 (en)	2003-06-05
SK2362001A3 (en)	2001-09-11
AU5515699A (en)	2000-03-14
BR9914288A (pt)	2001-06-19
US6686379B2 (en)	2004-02-03
SK285105B6 (sk)	2006-06-01
DE69901840T2 (de)	2003-05-22

Publication	Publication Date	Title
ATE219074T1 (de)	2002-06-15	Neue salzform von pantoprazol
TR200000782T2 (tr)	2000-09-21	Resorsinol türevleri.
IS6655A (is)	2002-12-12	Sýklópentanóindól, efnablöndur sem innihalda slíkefnasambönd og meðhöndlunaraðferðir
EA199900373A2 (ru)	1999-12-29	Фармацевтические композиции
PT1032542E (pt)	2004-11-30	Composicao de la mineral
ID27092A (id)	2001-03-01	Pembuatan ftalat anhidrida
ID29021A (id)	2001-07-26	Komposisi galantamina pelepasan terkontrol
ATE274348T1 (de)	2004-09-15	Überbrückte indenopyrrolocarbazole
ATE273984T1 (de)	2004-09-15	Selektive kristallisierung von 3-pyridyl-1- hydroxyethyliden-1,1-bisphosphonsäure natrium als hemipentahydrat oder monohydrat
FR2773169B1 (fr)	2004-12-03	Composition amelioree en bloc solide alcalin
ATE236899T1 (de)	2003-04-15	Neue kristallinische form des kaliumsalzes des (s)-omeprazols
MXPA03004904A (es)	2003-10-15	Proceso para la preparacion de alquilarilsulfonatos.
YU11401A (sh)	2004-03-12	Lokalne farmaceutske kompozicije koje sadrže nimesulid
EE200300294A (et)	2003-10-15	Sulfoonamiid-asendatud imidasotriasinoonide valmistamismeetod
TR199903132A3 (tr)	2000-07-21	Metalosan bilesiklerinin aktive edici kompozisyonu.
ATE265846T1 (de)	2004-05-15	Butorphanol enthaltende formulierungen mit verzögerter freisetzung
YU39201A (sh)	2004-07-15	Upotreba 1-arilpirazola za pripremanje oralnog sredstva za suzbijanje parazita
FI981810A0 (fi)	1998-08-24	Menetelmä alkuainepitoisuuksien määrittämiseksi
ID24327A (id)	2000-07-13	Produksi senyawa-senyawa avermektin
NO20025703L (no)	2002-11-27	Fremgangsmåte for fremstilling av vannfritt natriumperklorat
PT1088010E (pt)	2004-07-30	Producao de poliolefinas
DK1098878T3 (da)	2004-02-16	Bispiperidiner som antitrombotiske midler
ITRM20010309A0 (it)	2001-06-04	Procedimento per la produzione di composti perfluoro-organici mediante florurazione elettrochimica.
DE50207869D1 (de)	2006-09-28	Metallorganisches antitumormittel
DE60015353D1 (de)	2004-12-02	3-oxo-1-propansulfonsäure und -sulfonate